FITAMINS™, A CANNABIS STRATEGIC VENTURES BRAND, SIGNS MIXED MARTIAL ARTS FIGHTER AND UFC PIONEER, ARTHUR ‘ONE GLOVE’ JIMMERSON, AS BRAND AMBASSADOR

LOS ANGELES, November 13, 2018 — FITAMINS™, a wholly owned subsidiary of Cannabis Strategic Ventures, Inc. (OTC: NUGS), announced today that Art ‘One Glove’ Jimmerson, former professional boxer and Mixed Martial Arts fighter, Ultimate Fighting Championship Pioneer and coach, has partnered as a brand Ambassador FITAMINS. FITAMINS is a proprietary health and wellness formula containing […]

Growing Cannabis Industry Creates Space for New Strategies

New York NY – November 13, 2018 – As the cannabis industry continues to grow, companies are using a variety of strategies to secure their places within the sector.   The cannabis sector, currently worth over $9 billion in North America, is expected to hit $57 billion globally by 2027. This growth is being fueled […]

The Emergence of New CBD Products Dominating Cannabis Industry

Palm Beach, FL – (November 13, 2018) – According to the Brightfield Group, hemp-derived CBD, tinctures and oils – consumption forms focused on the ease of medicating – are making up nearly half (47%) of the total CBD market. In the marijuana-derived market tinctures and oils comprise just 7.4% of all sales, and sugar candy […]

MARIJUANA COMPANY OF AMERICA ANNOUNCES THE OFFICAL LAUNCH OF “ASONTV” HEMPSMART TV COMMERCIAL

Escondido, CA — (November 13, 2018) – MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC: MCOA), an innovative hemp and cannabis corporation, is pleased to announce the official launch of its television commercial ad campaign in conjunction with the Company’s strategic partner, asseenontv.pro (ASONTV), to market its hempSMART™ Full Spectrum Pet Drops.   The […]

BioSig Technologies Announces New Research Program with Mayo Clinic

New Agreement to Focus on Enhanced Features of PURE EP System and Future Potential Clinical Applications   Santa Monica, CA, Nov. 13, 2018 — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today […]